Valerie Galante
Adult Health · Wyomissing, PANPI 1720511843
Payments from drug & device makers
Across 536 payments — averaging $19.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Amgen$2K
- UCB, Inc.$1K
- Johnson & Johnson$1K
- AstraZeneca$627
- ANI Pharmaceuticals, Inc.$459
- plus $3K from 27 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 145 | $2,367 |
| Amgen(2 entities) | 102 | $2,122 |
| UCB, Inc. | 41 | $1,088 |
| Johnson & Johnson(2 entities) | 57 | $1,041 |
| AstraZeneca(2 entities) | 32 | $627 |
| ANI Pharmaceuticals, Inc. | 22 | $459 |
| GSK | 21 | $411 |
| Radius Health, Inc. | 9 | $280 |
| E.r. Squibb & Sons, L.L.C. | 13 | $261 |
| Aurinia Pharma U.S., Inc. | 10 | $234 |
| Lilly USA, LLC | 12 | $225 |
| Pfizer | 12 | $219 |
| Novartis | 8 | $186 |
| Mallinckrodt Hospital Products Inc. | 5 | $158 |
| Sobi, Inc | 5 | $118 |
| Genentech USA, Inc. | 6 | $103 |
| Organon | 5 | $96 |
| Sanofi | 4 | $89 |
| Kyowa Kirin, Inc. | 3 | $87 |
| Boehringer Ingelheim | 3 | $73 |
| Ultragenyx Pharmaceutical Inc. | 4 | $70 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $61 |
| Actelion Pharmaceuticals US, Inc. | 2 | $52 |
| Fresenius Kabi USA, LLC | 2 | $51 |
| Almatica Pharma LLC | 2 | $49 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $31 |
| Bioventus LLC | 2 | $29 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Alvogen Inc | 1 | $25 |
| Tersera Therapeutics LLC | 1 | $18 |
| Sandoz | 1 | $18 |
| Orthogenrx Inc. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
How this compares
$10,710 in reported general payments places this provider in the 95th percentile of 899 adult health providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other adult health in Wyomissing
- Beth SandyPhiladelphia$924K
- Diane NewmanPhiladelphia$413K
- Jennifer MondilloSchwenksville$396K
- Elizabeth FaustDouglassville$356K
- Abigail SmithPhiladelphia$302K
- Jean CainAllentown$214K
- Lauren MassimoPhiladelphia$139K
- Jennifer KeeleyWexford$97K
- Debra EvansFarrell$85K
- Bethann MallonBlue Bell$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.